Email Updates

You are here

Home

6 JANUARY 2023 VOLUME 25 ISSUE 1

Media Coverage

  • Killing of LGBTQ+ Activist Prompts Outcry Over Anti-Gay Attacks in Kenya

    Kenyan police are investigating the death of an LGBTQ+ rights activist whose body was discovered stuffed in a metal box in a killing that has provoked national outrage. Edwin Chiloba, a 25-year-old fashion designer and model, was found dead by the side of a road on Wednesday 25 miles (40km) outside the Rift Valley town of Eldoret in western Kenya, according to reports.

    January 6, 2023
    General
    The Guardian

  • Study Finds Higher Prevalence of HIV Among Women Experiencing Intimate Partner Violence

    Women who experience recent intimate partner violence (IPV) are three times more likely to contract HIV, according to a new study led by McGill University researchers. In regions like Sub-Saharan Africa, women face an intersecting epidemic of intimate partner violence and HIV. "Sub-Saharan Africa is among one of the regions in the world with the highest prevalence of both IPV and HIV. We wanted to examine the effects of intimate partner violence on recent HIV infections and women's access to HIV care in this region," he says.

    January 5, 2023
    General
    News Medical

  • Respecting the Power of the Pink Triangle

    The pink triangle was popularized by the HIV/AIDS grassroots activist group AIDS Coalition to Unleash Power (ACT UP) as an organizing emblem during the early days of the HIV/AIDS epidemic. But over the past 10 years, the upright triangle has become soaked in twee nostalgia and soulless corporatization. However, activists, historians and public figures in the queer community are reminding the world about its urgent role in fighting the ongoing HIV epidemic, while also calling attention to its nefarious past and evolution.

    January 4, 2023
    General
    TheBody

  • Most Countries Not on Track to Eliminate Hepatitis B and C by 2030

    Only 11 countries are on track to eliminate hepatitis C by 2030, and no country is are expected to eliminate hepatitis B in that time frame, according to study findings presented at the AASLD Liver Meeting. The Polaris Observatory uses epidemiological data to model the disease burden and economic impact of hepatitis B and C. Sarah Blach, an epidemiologist at the Center for Disease Analysis Foundation, and colleagues analyzed preliminary data for 2020 and 2021 to assess progress towards eliminating viral hepatitis.

    January 4, 2023
    General
    POZ Magazine

  • HIV-Positive People With Lymphoma Can Be Treated With CAR-T Therapy

    CAR-T therapy demonstrated acceptable safety and effectiveness for HIV-positive people with lymphoma, with outcomes comparable to those observed for HIV-negative patients, according to study results presented at the American Society of Hematology (ASH) annual meeting. People living with HIV are at higher risk for lymphoma than the general population.

    January 4, 2023
    General
    POZ Magazine

  • West Virginia Officials Block Clean Needle Programs Despite HIV Outbreak

    In August 2021, the Centers for Disease Control and Prevention (CDC) finished an investigation on an HIV outbreak in Kanawa County, West Virginia. The findings cited the county with “the most concerning HIV outbreak in the United States” and a warning that the reported diagnoses may only be “the tip of the iceberg.”

    January 3, 2023
    General
    Plus Magazine

  • Antibody Drugs Could Target Infectious Diseases — If Costs Come Down

    At a malaria research conference five years ago in Senegal, scientist Timothy Wells presented an overview of medicines on the horizon, ending with a few slides focused on an outlandish idea. Wells proposed that monoclonal antibody drugs — a class of high-price medicines that has transformed the treatment of cancer and autoimmune diseases — had a role in preventing malaria, a mosquito-borne disease that kills more than a half-million people each year, mostly children in Africa. Scientifically, it was plausible. Practically speaking, it seemed ludicrous.

    January 3, 2023
    General
    Washington Post

  • HIV Prevention: Why Aren’t More Heterosexual People Using PrEP?

    While preexposure prophylaxis, or PrEP, is a vetted, tried and true form of HIV prevention, messaging around the medication — which reduces the riskTrusted Source of contracting HIV from sex by roughly 99 percent and from injection drug use by 74 percent — is often directed toward members of the LGBTQ community.

    January 3, 2023
    PrEP
    Healthline

  • What Is HPV-Type Throat Cancer, and How Can It Be Prevented?

    Tennis great Martina Navratilova has been diagnosed with throat and breast cancer, which she described as a “double whammy” to tennis.com Monday. Calling the illnesses “serious but still fixable,” the 18-time Grand Slam singles winner said she was “hoping for a favorable outcome.” Navratilova’s Stage 1 throat cancer is related to the human papillomavirus (HPV), the most prevalent sexually transmitted infection in the United States, and the precursor to several cancers.

    January 3, 2023
    General
    Washington Post

  • This Is Life as a Trans HIV Activist in Religiously Conservative Tunisia

    Khookha McQueer is a Tunisian, nonbinary, feminist, activist trans woman. The artist and drag performer was raised by a conservative family in Ariana, a northern suburb of the capital, Tunis. In their 20s, they came out as a gay man, and later in 2015, they stepped into their identity as a nonbinary trans woman. Within Tunisia, it is still uncommon for LGBTQ+ people to share their identities publicly. That’s part of what makes McQueer’s status as one of the first trans women known to the general public so notable.

    January 2, 2023
    General
    TheBody

  • Non-AIDS Cancers on the Rise Among People With HIV in South Africa

    Cancers not related to HIV or infections are becoming more common in people with HIV in South Africa as they live longer, according to a study of 5.2 million people published in the journal Clinical Infectious Diseases. The study found that by 2012-2014, breast cancer had become the third most common cancer diagnosed in people with HIV in South Africa, behind two AIDS-defining cancers (cervical cancer and Kaposi’s sarcoma).

    January 2, 2023
    General
    aidsmap

  • Hepatitis C Is a Slow-Moving Killer That Can Be Stopped. What’s Getting in the Way?

    Michael Mendez said that when learned he had hepatitis C, “I didn’t even know what it was.” Mendez, 47, had been homeless for years in Los Angeles, and said he hadn’t gone to a doctor the entire time he was living on the streets. When Mendez got a roof over his head, at the Arroyo Seco Tiny Home Village, he decided to stop at the UCLA Health mobile clinic that rolled weekly to the Highland Park site — and soon learned about the infection that could jeopardize his life.

    January 1, 2023
    General
    Los Angeles Times

  • Anthony Fauci Quietly Shocked Us All

    The first time I met Dr. Anthony Fauci was at the International AIDS Conference in Montreal during the summer of 1989. ACT UP, the AIDS activist group I was a part of, had scared the bejesus out of conference organizers by seizing the stage during the opening session, then made things worse by disrupting various scientific presentations. Many, if not most, AIDS researchers wanted us hauled away and never heard from again. Little did they know that Dr.

    December 31, 2022
    General
    New York Times

  • A New HIV Treatment Shot Is Given Only Twice a Year. It Could Be a ‘Game Changer.’

    The Food and Drug Administration has approved Sunlenca, an injectable therapy to suppress HIV for patients who suffered drug resistance to other regimens. Experts say the new injectable, which works with less frequent dosing, can be a game changer for those whose infections don’t respond to other treatments.

    December 30, 2022
    Treatment
    USA Today

  • Herpes Vaccine Tests Underway by Company That Made COVID-19 Vaccines

    Ever since BioNTech and its occasional corporate partner Pfizer announced they had developed an mRNA vaccine for COVID-19, biotech researchers have salivated over the promise of using mRNA vaccines on other pathogens. That speaks to the promise of mRNA vaccines: unlike conventional vaccine platforms, mRNA vaccines can be much more easily modified to treat new viruses. That has opened the doors for the possibility of vaccines against viruses that had eluded immunologists, including retroviruses like HIV — for which researchers are already working on an mRNA vaccine.

    December 29, 2022
    STI Vaccines
    Salon

  • Experts Hail Possible Game-Changer in Fight Against Sexually-Transmitted Infections

    The San Francisco Department of Public Health issued guidance for Doxy-PEP, which can help prevent sexually transmitted infections (STIs) in certain groups by using a common antibiotic (doxycycline) to target specific infections like chlamydia, gonorrhea and syphilis. A recent study found that doxycycline post-exposure prophylaxis (Doxy-PEP) reduced STIs when used by some adults based on their medical history and sexual partners.

    December 29, 2022
    General
    CBS News

  • Dapivirine Ring Can Reduce HIV Infection by 50 Percent – NHVMAS

    New HIV Vaccine and Microbicide Advocacy Society, NHVMAS, says Pre-Exposure Prophylaxis, PrEP, ring, also known as dapivirine ring, can reduce HIV infection in women by 50 percent if strictly adhered to. PrEP is a drug people at risk of Human Immunodeficiency Virus, HIV, take to prevent contracting the virus from sex or injection drug use.

    December 28, 2022
    PrEP
    Daily Nigerian

  • Drug Could Beat Back HIV — If People Could Get It

    Night after night, Annet worries about contracting HIV. The single mother has moonlighted as a sex worker for years to supplement her income as the owner of a retail shop and support her young daughter. The viral threat looms each time she meets a client, particularly if the man offers to pay more to forgo using a condom — money she can’t always afford to turn down.

    December 20, 2022
    General
    Global Press Journal

Published Research

Announcements